Psoriatic Arthritis

Latest News

FDA Approves Biosimilar Ustekinumab-ttwe for All Indications of Reference Medicine
FDA Approves Biosimilar Ustekinumab-ttwe for All Indications of Reference Medicine

July 1st 2024

Pyzchiva will be commercialized by Sandoz in the United States.

Alice Gottlieb, MD, PhD: Preventing Pain and Disability in Psoriatic Disease
Alice Gottlieb, MD, PhD: Preventing Pain and Disability in Psoriatic Disease

June 13th 2024

MoonLake Immunotherapeutics Announces FDA, EMA Support of Furthering Phase 3 Sonelokimab for PsA
MoonLake Immunotherapeutics Announces FDA, EMA Support of Furthering Phase 3 Sonelokimab for PsA

June 10th 2024

Upadacitinib Available for Pediatric Patients with pJIA, PsA
Upadacitinib Available for Pediatric Patients with pJIA, PsA

June 4th 2024

Low Stress Resilience in Men Linked to Higher Risk of Psoriasis and Psoriatic Arthritis
Low Stress Resilience in Men Linked to Higher Risk of Psoriasis and Psoriatic Arthritis

May 29th 2024

Video Interviews
Podcasts
The Cutaneous Connection

More News

© 2024 MJH Life Sciences

All rights reserved.